HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$9.76
Day range
$9.35 - $10.03
Year range
$4.89 - $16.65
Market cap
640.74M USD
Avg Volume
605.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.43M | 42.09% |
Net income | -28.33M | -35.89% |
Net profit margin | — | — |
Earnings per share | -0.49 | 5.77% |
EBITDA | -31.16M | -42.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 208.19M | 0.93% |
Total assets | 252.01M | 1.95% |
Total liabilities | 27.92M | 12.45% |
Total equity | 224.09M | — |
Shares outstanding | 67.38M | — |
Price to book | 2.39 | — |
Return on assets | -29.85% | — |
Return on capital | -31.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -28.33M | -35.89% |
Cash from operations | -24.27M | -58.33% |
Cash from investing | 20.96M | -25.93% |
Cash from financing | 453.00K | -98.17% |
Net change in cash | -2.85M | -107.56% |
Free cash flow | -13.49M | -72.72% |
About
Founded
2014
Headquarters
Website
Employees
100
